← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksSRXHRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

SRx Health Solutions Inc. (SRXH) Revenue History

Annual and quarterly revenue from 2022 to 2023

TTM Revenue
$18.6M
vs. $92.6M LY
YoY Growth
-
Latest Quarter
$11.4M
Q2 2025
QoQ Growth
+59.9%
Excellent

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$118.9M (2023)
Highest Quarter$11.4M (Q2 2025)
Revenue per Share$1.50

Loading revenue history...

Revenue Growth Metrics

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year$74.0M (-79.9%)
Revenue per Share$1.50
Peak Annual Revenue$118.9M (2023)

Download Historical Data

2 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

SRXH Revenue Analysis (2022–2023)

As of March 2, 2026, SRx Health Solutions Inc. (SRXH) generated trailing twelve-month (TTM) revenue of $18.6 million. The most recent quarter (Q2 2025) recorded $11.4 million in revenue, up 59.9% sequentially.

Looking at the longer-term picture, SRXH's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $118.9 million in 2023, representing a new all-time high.

When compared to Healthcare sector peers including NVS (+8.6% YoY), and OGN (-2.9% YoY). Compare SRXH vs NVS →

Peer Comparison

Compare SRXH's revenue metrics with industry peers

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
SRXHCurrent$19M---4.9%
NVS$54.8B+8.6%+1.9%31.2%
OGN$6.2B-2.9%-1.0%20.7%
Best in groupLowest in group

Historical Revenue Data

Showing 2 of 2 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2023$118.9M+28.4%$23.6M19.9%$-5,807,515-4.9%
2022$92.6M-$13.3M14.4%$-1,166,410-1.3%

See SRXH's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is SRXH Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare SRXH vs AGIO

See how SRXH stacks up against sector leader Agios Pharmaceuticals, Inc..

Start Comparison

Frequently Asked Questions

Is SRXH's revenue growth accelerating or slowing?

SRXH TTM revenue: $19M. YoY growth: N/A. 5-year CAGR: N/A.

What is SRXH's long-term revenue growth rate?

SRx Health Solutions Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is SRXH's revenue distributed by segment?

SRXH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2023 are available for download. Segment mix reveals concentration and diversification trends.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.

Revenue Over Time